<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640454</url>
  </required_header>
  <id_info>
    <org_study_id>13-27-10</org_study_id>
    <nct_id>NCT04640454</nct_id>
  </id_info>
  <brief_title>Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer</brief_title>
  <official_title>Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is a form of&#xD;
      mastectomy that achieves optimal disease control and facilitates reconstruction. The study&#xD;
      aimed to assess the oncological safety and aesthetic outcomes of nipple-sparing mastectomy&#xD;
      and immediate breast reconstruction.&#xD;
&#xD;
      35 female patients with breast cancer were included in the study. The investigators&#xD;
      categorized the incisions into radial, inframammary, and periareolar incisions with planned&#xD;
      reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous&#xD;
      (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>patients complications after nipple sparing mastectomy</measure>
    <time_frame>2017-2019</time_frame>
    <description>Complete general examination, local examination of the skin, nipple and areola were done to determine whether the patients suffered from any complaints</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aesthetic results assessed by Tzafetta et al scoring system</measure>
    <time_frame>2017-2019</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">35</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nipple sparing mastectomy</intervention_name>
    <description>The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The mean age of the studied patients was 44.00±9.47 years old; the youngest patient was 28&#xD;
        years old and the oldest one was 68 years old, the majority of patients were 40-50 years of&#xD;
        age (54%) As regard the patients' marital status; 31 patients were married constituting&#xD;
        88.57 % and only 4 (11.4 %) patients were single The main complaint of 25 of them (71.42%)&#xD;
        was painless breast lump while 8 cases (22.85%) presented with local recurrence after&#xD;
        previous breast conservative surgery and only two case (5.7%) presented by extensive&#xD;
        mammographic calcifications on screening mammography&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of ductal in situ carcinoma or infiltrating ductal carcinoma with a tumor&#xD;
             diameter up to 3 cm&#xD;
&#xD;
          -  Distance of the tumor from the nipple ≥ 2 cm&#xD;
&#xD;
          -  Cancer or microcalcifications not localized in the central field.&#xD;
&#xD;
          -  No blood secretions or other (nipple-areola complex) NAC disturbances&#xD;
&#xD;
          -  Absence of skin involvement&#xD;
&#xD;
          -  Indication to mastectomy for multifocal or diffuse microcalcifications&#xD;
&#xD;
          -  Negative intraoperative assessment of NAC-bottom&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tumor or microcalcifications localized in the central quadrant or in the retroareolar&#xD;
             region&#xD;
&#xD;
          -  Blood secretions or other NAC alterations&#xD;
&#xD;
          -  Positive intraoperative assessment of NAC-bottom&#xD;
&#xD;
          -  Inflammatory carcinoma&#xD;
&#xD;
          -  Paget's disease of the nipple&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>28 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Alexandria faculty of medicine</name>
      <address>
        <city>Alexandria</city>
        <zip>21500</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 5, 2020</study_first_submitted>
  <study_first_submitted_qc>November 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>mastectomy</keyword>
  <keyword>breast reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

